Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-004784

Options or other derivatives

  • Head of Pharm Ops and Tech acquired 6,815 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2022-02-10 Grant or award · Restricted Stock Unit +6,815 6,815 D: show line 1 in the form
Loading xslF345X03/form4.xml…